Trending NewsTrending NewsNYSE:BDX Becton, Dickinson and Company (BDX) Stock Price, News & Analysis $212.27 -1.28 (-0.60%) Closing price 11/6/2026 03:59 PM EasternExtended Trading$211.86 -0.41 (-0.19%) As of 11/6/2026 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Becton, Dickinson and Company Stock (NYSE:BDX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BDX alerts:Sign Up Key Stats Today's Range$208.95▼$214.8850-Day Range$176.18▼$213.0552-Week Range$137.35▼$214.88Volume2.17 million shsAverage Volume1.60 million shsMarket Capitalization$58.49 billionP/E Ratio51.27Dividend Yield1.98%Price Target$193.67Consensus RatingModerate Buy Company Overview Becton, Dickinson and Company, commonly known as BD, is a global medical technology company that develops and manufactures products used in healthcare, clinical laboratories and life sciences research. Founded in 1897, the company has a long history of producing medical devices and supplies. BD’s products include syringes, needles, infusion systems and medication-management technologies, as well as equipment and supplies for collecting and processing clinical specimens. The company also provides diagnostic systems, laboratory instruments and tools used in areas such as cell analysis and biomedical research. Its offerings serve hospitals, clinics, laboratories, researchers and pharmaceutical companies. BD operates internationally and supplies customers across a broad range of geographic markets.AI Generated. May Contain Errors. Read More Becton, Dickinson and Company Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks70th Percentile Overall ScoreBDX MarketRank™: 3.52149810708 of 5 starsBecton, Dickinson and Company scored higher than 70% of companies evaluated by MarketBeat, and ranked 193rd out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingBecton, Dickinson and Company has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 8 buy ratings, 8 hold ratings, and 1 sell rating.Downside RiskBecton, Dickinson and Company has a consensus price target of $193.67, representing about 8.8% downside from its current price of $212.27.Amount of Analyst CoverageBecton, Dickinson and Company has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Becton, Dickinson and Company's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth5.89% Earnings GrowthEarnings for Becton, Dickinson and Company are expected to grow by 5.89% in the coming year, from $13.24 to $14.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Becton, Dickinson and Company is 51.27, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.50.Price to Earnings Ratio vs. SectorThe P/E ratio of Becton, Dickinson and Company is 51.27, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.54.Price to Earnings Growth RatioBecton, Dickinson and Company has a PEG Ratio of 13.39. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBecton, Dickinson and Company has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.25% of the float of Becton, Dickinson and Company has been sold short.Short Interest Ratio / Days to CoverBecton, Dickinson and Company has a short interest ratio ("days to cover") of 5.48.Change versus previous monthShort interest in Becton, Dickinson and Company has recently decreased by 8.88%, indicating that investor sentiment is improving significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldBecton, Dickinson and Company pays a meaningful dividend of 2.11%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthBecton, Dickinson and Company has been increasing its dividend for 53 years.Dividend CoverageThe dividend payout ratio of Becton, Dickinson and Company is 126.51%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Becton, Dickinson and Company will have a dividend payout ratio of 29.96% next year. This indicates that Becton, Dickinson and Company will be able to sustain or increase its dividend.Read more about Becton, Dickinson and Company's dividend. News and Social Media4.3 / 5News Sentiment0.86 News SentimentBecton, Dickinson and Company has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 40 news articles for Becton, Dickinson and Company this week, compared to 8 articles on an average week.Search Interest11 people have searched for BDX on MarketBeat in the last 30 days. This is an increase of 38% compared to the previous 30 days.MarketBeat Follows7 people have added Becton, Dickinson and Company to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Becton, Dickinson and Company insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,269,128.00 in company stock.Percentage Held by Insiders0.40% of the stock of Becton, Dickinson and Company is held by insiders.Percentage Held by Institutions86.97% of the stock of Becton, Dickinson and Company is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Becton, Dickinson and Company's insider trading history. Receive BDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Becton, Dickinson and Company and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BDX Stock News Headlines3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 YearsNovember 7 at 8:47 AM | 247wallst.comBecton, Dickinson and Company (NYSE:BDX) Initiates Share Repurchase ProgramNovember 7 at 1:13 AM | americanbankingnews.comTesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.Tesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a different approach, paying $452 in monthly cash on a $5,000 stake. Elon Musk recently floated a Tesla-SpaceX merger, but the dividend gap remains unchanged. Similar funds now exist for Apple, Amazon, Microsoft and Nvidia, each designed to turn big tech exposure into monthly income.November 7 at 1:00 AM | Investors Alley (Ad)Piper Sandler Adjusts Price Target on Becton, Dickinson and Company to $200 From $175November 6 at 11:39 AM | marketscreener.comMBecton Dickinson (BDX) Q4 2026 Earnings Call TranscriptNovember 5 at 8:28 PM | finance.yahoo.comBecton Dickinson Q4 2026: Beat on Both Lines, Free Cash Flow Up 42.5%November 5 at 3:27 PM | 247wallst.comBecton, Dickinson And Company Q4 Profit AdvancesNovember 5 at 3:27 PM | rttnews.comBecton, Dickinson and Company (NYSE:BDX) EVP Sells 76 Shares of StockOctober 28, 2026 | insidertrades.comSee More Headlines BDX Stock Analysis - Frequently Asked Questions How have BDX shares performed this year? Becton, Dickinson and Company's stock was trading at $194.11 at the beginning of 2026. Since then, BDX stock has increased by 9.4% and is now trading at $212.2710. How were Becton, Dickinson and Company's earnings last quarter? Becton, Dickinson and Company (NYSE:BDX) announced its quarterly earnings results on Thursday, November, 5th. The medical instruments supplier reported $4.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.07 by $0.08. The business's revenue for the quarter was up 5.4% on a year-over-year basis. Read the conference call transcript. How will Becton, Dickinson and Company's stock buyback program work? Becton, Dickinson and Company's board initiated a stock buyback plan on Thursday, November 5th 2026, which permits the company to repurchase 10,000,000 outstanding shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its stock through open market purchases. Stock buyback plans are often an indication that the company's leadership believes its shares are undervalued. Does Becton, Dickinson and Company have any subsidiaries? Becton, Dickinson and Company subsidiaries include these companies: Cytognos, Scanwell Health Inc., Tissuemed Ltd., Venclose Inc., Tepha Inc., Velano Vascular, GSL Solutions, and others. Who are Becton, Dickinson and Company's major shareholders? Becton, Dickinson and Company's top institutional investors include Beutel Goodman & Co Ltd. (0.67%), ProShare Advisors LLC (0.41%), Fort Washington Investment Advisors Inc. OH (0.40%) and Cooke & Bieler LP (0.31%). Insiders that own company stock include Thomas E Polen Jr, Bertram L Scott, Claire Fraser, Michael Feld, Shana Carol Neal, Roland Goette, Michael David Garrison, Jeffrey William Henderson, Richard Byrd, Richard Byrd, David Shan and Thomas J Spoerel. View institutional ownership trends. How do I buy shares of Becton, Dickinson and Company? Shares of BDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Becton, Dickinson and Company own? Based on aggregate information from My MarketBeat watchlists, some other companies that Becton, Dickinson and Company investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), AbbVie (ABBV), Chevron (CVX), ExxonMobil (XOM) and Abbott Laboratories (ABT). Company Calendar Record date for 9/30 Dividend9/09/2026Ex-Dividend for 9/30 Dividend9/09/2026Dividend Payable9/30/2026Last Earnings11/05/2026Today11/07/2026Record date for 12/31 Dividend12/10/2026Ex-Dividend for 12/31 Dividend12/10/2026Investor Day 202612/10/2026Dividend Payable12/31/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 BDX's financial health is in the Green zone, according to TradeSmith. BDX has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BDX CIK10795 Webwww.bd.com Phone(201) 847-6800Fax201-847-6475Employees72,000Year Founded1897Price Target and Rating Average Price Target for Becton, Dickinson and Company$193.67 High Price Target$242.00 Low Price Target$150.00 Potential Upside/Downside-8.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage18 Analysts Profitability EPS (Trailing Twelve Months)$3.32 Trailing P/E Ratio51.27 Forward P/E Ratio15.14 P/E Growth13.39Net Income$1.68 billion Net Margins4.52% Pretax Margin8.59% Return on Equity14.79% Return on Assets6.93% Debt Debt-to-Equity Ratio0.55 Current Ratio0.87 Quick Ratio0.51 Sales & Book Value Annual Sales$21.84 billion Price / Sales2.68 Cash Flow$24.68 per share Price / Cash Flow8.60 Book Value$88.58 per share Price / Book2.40Miscellaneous Outstanding Shares275,540,000Free Float274,438,000Market Cap$58.49 billion OptionableOptionable Beta0.22 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:BDX) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredOne Ticker Tied to a Coming 401k ChangeAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredTesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.Tesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a differen...Investors Alley | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Becton, Dickinson and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Becton, Dickinson and Company With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDX Stock Alerts